¿Es dea-lauraminopropionate seguro durante el embarazo?
No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
Related ingredients
Frequently asked questions
- ¿Es dea-lauraminopropionate seguro durante el embarazo?
- No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
- ¿Es dea-lauraminopropionate seguro durante la lactancia?
- No data indicate DEA‑lauraminopropionate is classified as a reproductive or lactation hazard; breastfeeding risk would be driven by maternal systemic absorption of DEA moiety, for which no human milk transfer data were identified. Theoretical mechanistic concern derives from DEA animal data, but there is no product‑specific evidence showing transfer into breast milk. (Sources: CIR / DEA literature; PubMed animal study.)
- ¿Es dea-lauraminopropionate seguro para la piel del bebé?
- There are no infant‑specific toxicity or classification data for DEA‑lauraminopropionate. Following conservative exposure considerations, measurable dermal absorption in adults (low) is expected to be higher in infants because of immature skin and higher surface‑area‑to‑body‑weight, so exposure score is increased by +1; hazard remains based on absence of direct evidence for this compound and reliance on theoretical concern from the DEA moiety. (Sources: regulatory INCI listings; DEA animal data.)
- ¿Cómo puntúa VeriMom a dea-lauraminopropionate?
- VeriMom puntúa dea-lauraminopropionate en 87/100 (riesgo bajo) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dea-lauraminopropionate en el embarazo?
- Consulta nuestra lista de alternativas seguras a dea-lauraminopropionate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.